Log in
(Ad)
In early 2019 President Trump warned this company's biggest customers to "step up their 5G efforts." A few months later, he banned their biggest competitor from doing business in the U.S. Now, this $5 stock could turn a $10,000 stake into $234,770 this year. But timing is critical. A single mention on the evening news and this opportunity could get away from you.

NYSE:GCO - Genesco Stock Price, Forecast & News

$44.35
+0.74 (+1.70 %)
(As of 01/23/2020 06:27 AM ET)
Today's Range
$43.87
Now: $44.35
$44.88
50-Day Range
$36.56
MA: $47.15
$52.21
52-Week Range
$31.65
Now: $44.35
$53.20
Volume250,500 shs
Average Volume237,861 shs
Market Capitalization$651.95 million
P/E RatioN/A
Dividend YieldN/A
Beta0.57
Genesco Inc operates as a retailer and wholesaler of footwear, apparel, and accessories. The company operates through four segments: Journeys Group, Schuh Group, Johnston & Murphy Group, and Licensed Brands. The Journeys Group segment offers footwear and accessories through the Journeys, Journeys Kidz, and Little Burgundy retail chains, as well as through e-commerce and catalogs for young men, women, and children. Read More…

Industry, Sector and Symbol

Industry Shoe stores
Sub-IndustryApparel Retail
SectorRetail/Wholesale
CUSIP37153210
Phone615-367-7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.19 billion
Cash Flow$7.42 per share
Book Value$36.47 per share

Profitability

Net Income$-51,930,000.00

Miscellaneous

Employees21,000
Market Cap$651.95 million
Next Earnings Date3/12/2020 (Estimated)
OptionableOptionable

Receive GCO News and Ratings via Email

Sign-up to receive the latest news and ratings for GCO and its competitors with MarketBeat's FREE daily newsletter.


(Ad)

If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

Genesco (NYSE:GCO) Frequently Asked Questions

What is Genesco's stock symbol?

Genesco trades on the New York Stock Exchange (NYSE) under the ticker symbol "GCO."

How will Genesco's stock buyback program work?

Genesco announced that its board has authorized a stock buyback program on Friday, May 3rd 2019, which permits the company to repurchase $100,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy up to 11.7% of its shares through open market purchases. Shares repurchase programs are often an indication that the company's board believes its shares are undervalued.

How were Genesco's earnings last quarter?

Genesco Inc. (NYSE:GCO) released its quarterly earnings data on Friday, December, 6th. The company reported $1.33 earnings per share for the quarter, topping analysts' consensus estimates of $1.10 by $0.23. The business earned $537.30 million during the quarter, compared to the consensus estimate of $540.64 million. Genesco had a positive return on equity of 10.98% and a negative net margin of 1.74%. Genesco's revenue was down .5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.95 earnings per share. View Genesco's Earnings History.

When is Genesco's next earnings date?

Genesco is scheduled to release their next quarterly earnings announcement on Thursday, March 12th 2020. View Earnings Estimates for Genesco.

What guidance has Genesco issued on next quarter's earnings?

Genesco updated its FY20 earnings guidance on Monday, January, 13th. The company provided earnings per share (EPS) guidance of above $4.10-4.40 for the period, compared to the Thomson Reuters consensus estimate of $4.30.

What price target have analysts set for GCO?

4 brokers have issued 1-year target prices for Genesco's shares. Their forecasts range from $52.00 to $58.00. On average, they anticipate Genesco's stock price to reach $55.00 in the next year. This suggests a possible upside of 24.0% from the stock's current price. View Analyst Price Targets for Genesco.

What is the consensus analysts' recommendation for Genesco?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genesco in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Genesco.

What are Wall Street analysts saying about Genesco stock?

Here are some recent quotes from research analysts about Genesco stock:
  • 1. According to Zacks Investment Research, "Genesco Inc., a Nashville-based specialty retailer, sells footwear, headwear and accessories in retail stores in the United States and Canada. The Company sells its products principally under the names Journeys, Journeys Kidz, Shi by Journeys, Johnston & Murphy, Underground Station, Hatworld, Lids, Hat Shack, Hat Zone, Head Quarters and Cap Connection, and on internet websites. The Company also sells footwear at wholesale under its Johnston & Murphy brand and under the licensed Dockers brand. " (12/10/2019)
  • 2. Pivotal Research analysts commented, "We’re shocked by how well 1Q turned out, especially for Journeys, given that 1Q was not the best quarter for many retailers. In retrospect, we should’ve been less bearish going into this print as TLYS posted a +LDD% footwear comp earlier this week, and there’s some footwear overlap between the two companies, namely Vans. GCO’s shares were deservedly up 10%+ on the print. But the question at hand is where do they go from here? Given the material 1Q outperformance at Journeys, we suspect that there’s upside to the 2Q guidance, but it is a more difficult comparison, and comparisons remain challenging over the balance of the year, with the back half a bigger question mark in our view on strong boot sales last year, which is a highly weather-dependent category." (6/3/2019)

Has Genesco been receiving favorable news coverage?

Media headlines about GCO stock have been trending somewhat positive recently, according to InfoTrie. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Genesco earned a media sentiment score of 2.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Genesco.

Are investors shorting Genesco?

Genesco saw a increase in short interest in December. As of December 31st, there was short interest totalling 3,180,000 shares, an increase of 10.8% from the December 15th total of 2,870,000 shares. Based on an average daily trading volume, of 308,300 shares, the days-to-cover ratio is presently 10.3 days. Approximately 23.0% of the shares of the stock are sold short. View Genesco's Current Options Chain.

Who are some of Genesco's key competitors?

What other stocks do shareholders of Genesco own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Genesco investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Bank of America (BAC), Intelsat (I), Chipotle Mexican Grill (CMG), Transocean (RIG), NIC (EGOV), Ciena (CIEN) and Continental Resources (CLR).

Who are Genesco's key executives?

Genesco's management team includes the folowing people:
  • Mr. Robert J. Dennis, Chairman, Pres & CEO (Age 65)
  • Ms. Mimi Eckel Vaughn, Sr. VP of Fin. & CFO (Age 52)
  • Mr. Paul D. Williams, VP & Chief Accounting Officer (Age 64)
  • Mr. Parag D. Desai, Sr. VP of Strategy & Shared Services (Age 44)
  • Mr. Danny Ewoldsen, Pres of Johnston & Murphy division

Who are Genesco's major shareholders?

Genesco's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Smith Graham & Co. Investment Advisors LP (1.09%), State of Alaska Department of Revenue (0.07%), Wealthstreet Investment Advisors LLC (0.03%), Louisiana State Employees Retirement System (0.03%), Huntington National Bank (0.03%) and Advisors Preferred LLC (0.01%). Company insiders that own Genesco stock include Daniel E Ewoldsen, Kathleen Mason, Mario Gallione, Marty G Dickens, Robert J Dennis and Thurgood Marshall Jr. View Institutional Ownership Trends for Genesco.

Which major investors are selling Genesco stock?

GCO stock was sold by a variety of institutional investors in the last quarter, including Smith Graham & Co. Investment Advisors LP, Wealthstreet Investment Advisors LLC, Huntington National Bank, Louisiana State Employees Retirement System and State of Alaska Department of Revenue. Company insiders that have sold Genesco company stock in the last year include Daniel E Ewoldsen, Kathleen Mason, Mario Gallione, Marty G Dickens, Robert J Dennis and Thurgood Marshall Jr. View Insider Buying and Selling for Genesco.

Which major investors are buying Genesco stock?

GCO stock was purchased by a variety of institutional investors in the last quarter, including Advisors Preferred LLC. View Insider Buying and Selling for Genesco.

How do I buy shares of Genesco?

Shares of GCO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Genesco's stock price today?

One share of GCO stock can currently be purchased for approximately $44.35.

How big of a company is Genesco?

Genesco has a market capitalization of $651.95 million and generates $2.19 billion in revenue each year. The company earns $-51,930,000.00 in net income (profit) each year or $3.28 on an earnings per share basis. Genesco employs 21,000 workers across the globe.View Additional Information About Genesco.

What is Genesco's official website?

The official website for Genesco is http://www.genesco.com/.

How can I contact Genesco?

Genesco's mailing address is GENESCO PK 1415 MURFREESBORO RD, NASHVILLE TN, 37217. The company can be reached via phone at 615-367-7000 or via email at [email protected]


MarketBeat Community Rating for Genesco (NYSE GCO)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  398 (Vote Outperform)
Underperform Votes:  582 (Vote Underperform)
Total Votes:  980
MarketBeat's community ratings are surveys of what our community members think about Genesco and other stocks. Vote "Outperform" if you believe GCO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GCO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel